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1. Introduction 
Cell surface glycosphingolipids are thought o be 
implicated in processes of cell-cell recognition and 
growth regulation, receptor function, and malignant 
transformation [l-3]. The identification and the 
structural analysis of these membrane components 
are also expected to afford an insight into the process 
of thymusderived (T) and bone marrow-derived (B) 
lymphocyte differentiation, since activated T and B 
lymphocytes express different sets of glycosphingo- 
lipids f4,5]. It is, therefore, not unre~onable to 
assume that tumour celi lines of T and of B cell origin 
will each yield characteristic glycosphingolipid dis- 
tribution patterns relating either to the expression of 
tumour-associated moieties or- to components typical 
for certain functional states during differentiation 
and/or maturation. 
Here, spontaneous orchemically induced, trans- 
plantable murine T and B lymphoblastoid tumours, 
adapted to in vitro conditions of growth [6,7] were 
used in a comparative qualitative and quantitative 
study of ganglioside and neutral glycolipid distribu- 
tion patterns revealed by hip-performance thin-layer 
chromatography (HPTLC) after biosynthetic sugar 
labelhng [51. We document here differences not only 
between T and B cell lines but also among T and 3 
cell lines that may be used as biochemical markers. 
2. Materials and methods 
The lymphoblastoid tumour cell Lines used were 
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8azaguanine-resistant myeloma nd B celi hybridoma 
lines, originally derived from Balbjc myeloma 
MOPC 2 1, several AKR thymomas, one C57BLf6 
thymoma, and two Fey-receptor bearing T cell 
hybridomas (table 1). These ceil lines were cultivated 
in quadruplicates for 72 h in Dulbecco’s modified 
Eagle’s medium, containing 15% foetal calf serum, 
using COSTAR, no. 3524 (Cambridge, MA), tissue 
culture plates; only Spl/HK was grown in the pres- 
ence of 15% horse serum. Initial cell concentrations 
were 5 X 10’ cells/mi. Both 0.5 @I@nl D-[1-‘4C]- 
galactose (spec. act. 53.3 Ci/moI) and 0.5 BCifml 
D-[ l-‘4~]~ucos~~e hydrochloride (spec. act. 
55.4 &i/moi), both from New England Nuclear, were 
present for the 72 h cultivation period. Cells were 
harvested by centrifugation (300 X g) in glass tubes, 
washed twice with phosphate-buffered saline, and 
they were repeatedly extracted with chloroform: 
methanol (2: 1 and 1: I, v/v) [5,14]. contaminating 
free radioactive sugars were removed by apartition 
procedure as in [ 151. Lipid-bound radioactivity was 
counted in Aquasol scintillator using an Intertech- 
nique liquid scintillation counter (Model SL4000, 
Nucletron SA, Lausanne). 
To achieve a more precise qualitative and quan- 
titative determination of the material that had been 
biosyn~etic~ly labelled by this procedure, extracted 
lipids from -1 O3 cells grown i  100 ml COSTAR 
no. 3 150 culture flasks were partitioned by a modi- 
fied Folch procedure [161. Upper phases, containing 
mainly gangliosides, were xtensively dialysed against 
cold distilled water. The lower phases, comprising 
mainly phospholipids and neutral glycolipids, were 
acetylated and subsequently fractionated by Florisil 
column chromatography according to [ 161. The 
neutral glycolipids obtained by this procedure and 
the gangliosides from the aqueous phase were then 
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analysed separately on Merck silica HPTLC plates 
on the basis of polarity. Bands of glycohpids, that 
were labelled by [ 14C] galactose and [ r4C] glucosamine, 
were developed by autoradiography on Kodak RP. 
Royal X-Omat X-ray films. For comparison CBA/J 
mouse brain gangliosides, and globotriaosylceramide 
of human erythrocytes as well as gan~iotetraosyl- 
ceramide of acid-treated human brain gan~iosides 
were applied as cold references, and they were stained 
with resorcinol and orcinol, respectively [ 141. 
3. Results 
Incorporation rates of r4C-Iabelled sugars varied 
with different cell lines. This property correlates with 
the observed growth rates: e.g., clone E-7 has a con- 
siderably lower doubling time and a lower rate of 
incorporation of rQC-labelled sugars than its parent 
line T2D4 {table 1). Gan~ioside (fig.1) and neutral- 
glycolipid (fig.2) patterns of Con A and LPS stimu- 
lated spleen cell cultures yielded the established 
reference patterns for T and B lymphocyte stimula- 
tion [5]. These patterns were obtained with all of 
10 inbred-mouse strains tested so far (G. R., unpub- 
lished). 
Thymomaderived ganglioside and neutral glyco- 
lipid distribution patterns are altogether distinct from 
myeloma-associated patterns. The two cell types 
show the greatest differences at the level of labefled 
gangliosides (fig.1). Myeloma lines X63 and 
X63-Ag8.653, and B cell hybridoma lines Sp2/0 and 
Spl/HK incorporate 80-90% of the ganglioside- 
associated radioactivity into a unique and closely 
circumscribed cluster near the GM3 range (table 2); 
this group of gangliosides accounts for only 5 5% of 
the LPS-stimulated B-cell patterns (table 2). It is 
interesting that hybridoma Sp2/0, a non-immuno- 
globulin secreting line [lo], consistently shows an 
inversion in strength of band R, 1.53 over band 
RF 1.45 with a somewhat reduced band RF 1.36 in 
comparison with X63 (table 2). Gangliosides of the 
haematoside series (GM3) separate in this chroma- 
tographic system according to the nature of their 
sialic acids, but also according to the polarity of 
their ceramides [ 171. The neutral glycolipid pat- 
terns of the X63 myeloma and its derivative lines 
X63-Ag8.653, Spl~HK, and Sp2/0 show considerable 
overlaps with the LPS-stimulated B-cell associated 
patterns (fig.2). However, in contrast to those, 
tetraosylceramides are minor components. Double 
bands in this system represent glycolipids with 
common sugar moieties, but different ceramides 
(table 3; G. R., unpublished). Thus, the differences 
are likely to relate to distinct activities of the 
enzymes involved in the biosyn~esis of ceramides. 
Ganglioside patterns of thymomas and T-cell 
hybridomas are highly variable (fig.1, table 2). 
Table 1 
Incorporation efficiency of “C-iabelled galactose and glucosamine into lipids of 10’ cells 
Cell linea Hybridoma linea Mouse strain Cell-surface markers cpm 
1. P3/X63 Ag8 (X63) - BALB/c H-2d 2488825782 
2. X63-Ag8.653 - BALB/c n-2d 14 951 + 569 
3. - Spl/HK BALB/c H-2d 13652k 708 
4. - Sp2/0-Ag14 (SpZ/O) BALB/c H-2d 12 405 + 860 
1. BW.5147 - AKR H-2k; Thy-l .l 5671 f 1137 
2.344TCll AKR H-2k; Thy-l .l 8823 f 1572 
3.369 TC AKR H-2k; Thy-l.1 4378 + 2605 
4.424AJ 1 - AKR H-2k; Thy-l .I 33390* 2957 
5. EL-4 Bu(EL-4)’ - CS7BL/6 H-2b 2339922788 
6. - T2D4 AKR x BlO.BR H-2k; Thy-l .l, Thy-l .2 21822*2234 
7. - E-7 AKR X BlO.BR H-2k; Thy-l .l, Thy-l .2 6139 + 1536 
The cell and hybridoma lines X63 [S], Spl/HK 191, SpZ/O [lo] and BWSl47 [ 111 were obtained from Dr G. KGhler, Basle Insti- 
tute for Immunology; X-63Ag8.653 [ 121 -aas from Dr T. Imanishi-Kari, Institut fur Genetik, Cologne; 344TCll,36YTC, and 42411 
thymomas were from Dr P. Krammer, Deutsches Krebsforschungs Zentrum, Heidelberg; T2D4 [ 131 hybridoma (AKR thymoma 
BW5 147 x BlO.BR m vivo alloantigenactivated T cells) and clone E-7 [ 131 derived from it were from Dr W. H. Fridmann, Insti- 
tut de Recherches Scientifiques sur le Cancer, Villejuif 
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Fig.1. Silica gel HPTLC labelling patterns of gangliosides extracted from cell pellets of lymphoma cell lines (table 1) BW 5 147 (A), 
EL4 Bu (B), 344TCll (C), T2D4 (D), E-7 (E), X63 (G), X63-Ag8.653 (H), Sp2/0 (I), and Spl/HK (K), and from Con A (F) and 
LPS (L; from Salmonella minnesoru R595)stimulated DBA/Zf Born mouse spleen cells. About 5000 cpm of every sample were 
applied to HPTLC plates (Merck, Darmstadt) silica gel 60, size 10 x 10 cm, thickness 0.24 mm using an automatic sample aPPli- 
cator (Linomat III, CAMAG, Muttenz, Switz.). The plates were developed in a solvent system of chloroform:methanol:water 
(55:45: 10, v/v/v, containing 1 mM CaCl,). Autoradio~aphy on Kodak RP Royal X-Gmat X-ray films (exposure time 1 week) 
served for band identi~cation. CBA/J mouse brain gangliosides chosen as cold reference substances were visualized by staining 
with resorcinol [ 141. 
a B C D E F G 
Gangliosides expressed by BW5 147 and EL-4 are 
totally different, and thymoma 344TCll is charac- 
terized by a third pattern, more similar to that of 
Con A-activated splenic T cells than those shown by 
the other two thymomas. The two T-cell hybridomas 
T2D4 and E-7, a clone of the T2D4 line [ 131, display 
largely overlapping patterns, partly resembl~g those 
of 344TCll and Con A-activated cells. Clone E-7, 
Fig.2. Silica gel HPTLC labelling patterns of neutral glyco- 
lipids extracted from cell pellets of lymphoma lines (table 1) 
BW5147 (A), EL4 (B), T2D4 (C), E-7 (D), and from Spl/HK 
(F), and from Con A (E), and LPS (C)stimulated DBA/2f 
Born mouse spleen cells. Application, autoradiography, and 
developing of the plates was as in fig.1, except that a solvent 
system consisting of c~oroform:me~anol:water (120:70: 17, 
v/v~v) was used, and globotriaosyl ceramide of human eryth- 
rocytes and gangliotetraosylceramide of acid-treated human- 
brain gangliosides were applied as cold references, stained 
with orcinol [ 141. 
215 
Table 2 
Quantitative valuation of radioactivity present in ganglioside bands developed on Silica HPTLC plates (see tig.l)a 
R P value Thymoma and T-cell hybridoma lines Con A Myeloma and B-cell hybridoma lines LPS 
of bandsb 
BW5147 344TCll T2D4 E-7 EL-4 X63 X63-Ag8.653 SP2/0 Spl/HK 
2.03 5.3 
1.95 7.9 1.5 
1.81 3.0 
1.71 2.7 2.2 1.2 1.6 
1.62 8.8 
1.56 17.0 
1.53 1.0 26.5 25.6 47.2 28.6 1.8 
1.45 42.4 37.3 30.2 45.8 1.7 _ 
1.36 19.9 18.2 9.6 16.6 2.0 
1.19 2.3 2.5 7.6 3.2 5.3 
1.10 2.3 7.2 3.4 
1 .oo 12.7 4.4 25.2 
0.95 13.4 23.6 55 2 _ 512 _  1.4 12.8 26.9 
0.89 5.4 22.6 20.2 22.5 16.4 11.7 
0.79 7.1 2.4 1.7 17.1 4.2 
0.75 18.6 5.6 1.4 1.2 8.0 5.1 4.6 
0.63 7.9 2.9 1.6 2.0 2.4 
0.56 5.0 6.5 3.4 25.4 4.4 1.2 
0.48 2.7 2.3 2.1 3.3 
0.41 1.2 1.4 1.6 
0.21 1.9 
yield 64.2 90.9 89.4 89.9 75.4 71.5 88.8 81.1 87.0 91.0 
a Areas of HPTLC silica gel corresponding to bands developed by 14C-label on X-ray films were scraped off and counted in 
Aquasol (New England Nuclear, Dreieich). Percentages are based on total recoveries per sample in bands and background areas. 
This recovery was -6O-80% of applied radioactivity. Bands accounting for <l% were omitted 
b RF values were expressed relative to mouse brain ganglioside GM, = 1 .OO as added standard 
Table 3 
Quantitative valuation of radioactivity present in neutral glycolipid bands developed on silica HPTLC plates (see fig.2)a 
RF value Thymoma and T-cell hybridoma lines Con A Myeloma and B-cell hybridoma lines LPS 
of bandsb 
BW5 147 344TCll T2D4 E-7 EL4 X63 X63-Ag8.653 Spl/HK 
2.00 
1.84 
1.75 
1.68 
1.32 
1.25 
1 .oo 
0.95 
0.89 
0.80 
0.74 
0.68 
0.64 
0.55 
0.50 
yield 
3.3 7.3 
3.1 5.5 
33.4 7.8 
20.4 7.0 
3.3 5.1 
3.1 5.4 
2.4 10.0 
3.7 
69.0 51.8 80.1 88.1 86.1 81.0 76.5 77.7 75.7 83.6 
1.6 1.1 5.0 
1.4 1.2 
6.7 1.6 6.8 17.4 17.7 16.3 
2.4 1.1 7.1 14.7 20 _1 8.6 
35.3 45.4 6.2 5.6 8.5 22.1 
14.8 21.0 5.6 2.8 5.6 18.0 
1.5 1.0 8.7 4.4 
2.2 1.6 27.6 5.2 8.6 4.1 
1.3 1.3 31 _I 4.1 
8.9 9.9 1.1 17.6 3.7 2.1 
2.9 2.9 7.4 3.3 2.1 
1.1 1.2 
1.5 
14.7 18.3 
9.9 8.8 
14.2 11.4 
10.3 6.2 
16.7 4.8 
9.9 7.2 
3.8 
2.1 
2.3 
9.0 
53 
3.2 
a Method as described in legend of table 2. Bands accounting for <l% were omitted 
b RF values were expressed relative to human erythrocyte triosylceramide I 
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appears to express somewhat greater variability than 
its parent line. The similarities between T2D4- and 
E-7-associated patterns extend to the neutral &CO- 
lipids, showing again the greatest overlaps with 
Con A-stimulated splenic T cells. Similarities are 
also seen with BWS 147 neutral glycolipids (table 3). 
EL4 thymoma cells of C57BL/6 mouse origin are 
very distinct from the above patterns. 
4. Discussion 
The differences in [ “C]galactose- and [ r4C]glucos- 
amine-labelled ganglioside and neutral-glycolipid 
distribution patterns observed upon HPTLC analy- 
sis of B and T lymphocytic tumour cell lines and 
hybridomas may reflect tumour-associated or func- 
tional properties, depending on the activities of the 
various enzyme systems involved in the metabolism 
of glycosphingolipids, e.g., sugar transferases and 
hydrolases, acyltransferases. The biochemical analysis 
of glycosphingolipids of lymphocytes appears to be a 
new and promising avenue of marker evaluation. It 
is for this reason that we undertook these studies. 
Glycosphingolipids of cell surfaces are possible 
receptors for mitogen action [18,19]; they have been 
associated with Thy-l alloantigens, and it has been 
suggested that they regulate the cell cycle and cell 
growth in immune responses [20]. Functional dif- 
ferences, e.g., of T cells, may, therefore, find their 
structural correlates in the nature of these constitu- 
ents of eukaryotic cell membranes. In fact, we have 
suggestive vidence that glycosphingolipid patterns 
permit differentiation between T, and cytotoxic 
T cells (G. R., M. H. Schreier, D. G. B., unpublished). 
The Fey-bearing T, hybridoma T2D4 and E-7-asso- 
ciated glycosphingolipid patterns discussed here 
appear to resemble a third functional subset of 
T cells, rather similar to patterns of Con A-stimulated 
T cells. These were reported to constitute T suppressor 
(TS) cells [2]. It is interesting that ganglioside pat- 
terns of T2D4 and E-7 cells bear little resemblance 
to that of BW5 147 thymoma, although this line was 
used for fusion [ 131. Both hybridomas, however, 
express strain AKR T cell-like patterns of the type 
shown by thymoma 344TCll cells, i.e., 14C-labelled 
bands are distributed over the area of GM1 
(monosialo-) and GDla (disialo-) gangliosides. T2D4 
and E-7 are Fey-bearing T-cell hybridomas [ 131. 
Therefore, 344TCll cells may also represent a TS cell 
population [22]. The evidence that Con A activates 
mainly T, cells [20] would be compatible with the 
observed similarity of patterns, provided T cell- 
ganglioside distribution patterns can be associated 
with functional properties. On the basis of this rea- 
soning, it is possible that thymoma line 344TCll 
may also exert suppressive activity on immune 
responses. The distinct ganglioside and neutral glyco- 
lipid patterns of EL4 cells may relate to functional 
differences associated with these T cells before they 
were transformed into tumour cells; they may also 
reflect genetic difference within the MHC. 
Ganglioside patterns of the myeloma cell lines 
X63, X63-Ag8.63.5, Spl/HK and Sp2/0 deserve 
special mentioning. Cell lines X63 and Spl/HK still 
secrete immunoglobulins while cell lines X63-Ag8.653 
andSp2/0donot [8-121. LinesX63 and X63-Ag8.653 
are myelomas, whereas lines Sp2/0 and Spl/HK are 
hybridomas. Despite their different historical back- 
ground, these 4 lines share the property that 80-90% 
of the [i4C]galactose and [ 14]glucosamine cluster in 
the GM3 range. This area, however, contains only 
5-6% of gangliosides expressed by polyclonal (LPS) 
B-cell stimulation (table 2). The inversion of band 
strength in line Sp2/0 is unlikely to be associated 
with the loss of immunoglobulin production by 
this line, since line X63-Ag8.653, also being a non- 
secretory B cell tumour, lacks it. However, this 
finding identifies a biochemical marker by which 
the two lines may be distinguished. It remains to be 
established whether ganglioside restriction to the GM3 
class may be generally associated with plasma cells. 
The isolation of specific glycosphingolipids on 
a preparative scale for further structural analysis and 
for the use in competition experiments is now fea- 
sible. In addition, highly specific anti-glycosphingo- 
lipid antibodies have recently been produced by the 
hybridoma approach [23]. These advances in glyco- 
sphingolipid research should soon be used to accu- 
mulate critical information about the functional 
properties of this category of membrane compo- 
nents. Tumour lines with certain pattern restrictions 
as well as specially identified hybridoma lines will 
be indispensible for the isolation of critical amounts 
of this material. 
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